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Abstract
Purpose: The purpose of this evidenced-based education project was (i) assess current barriers
and determining factors associated with medication adherence and how this coincides with health
outcomes, (ii) assess whether medication adherence and hospital re-admission rates were
improved with a comprehensive medication discharge educational plan.
Setting: The project took place on a 35 bed post interventional care unit (4IC) located in a
433 bed community care hospital in Central Kentucky.
Population: The population for this study was a sample of 10 acute myocardial infarction
patients post percutaneous coronary intervention. Thirty percent of participants were female and
60% were male. Mean age was 63.6 years old (SD=10.5).
Inclusion Criteria: English speaking subjects who were post percutaneous coronary
intervention and discharged on anti-platelet medication. Access to a phone for the 7 day post
discharge phone call was a requirement for study participation.
Design and Methods: Data analysis was performed using SPSS® version 23.0 (SPSS Inc.,
Chicago, IL). Pre and post tests were scored and statistically analyzed to assess mean scores
prior to, and following educational intervention. Data were analyzed using descriptive statistics.
Paired T-tests were conducted to compare the differences in mean scores. This study considered
values of p < 0.0001 significant for the analysis. Enrolled patients were seen on the morning of
hospital discharge and the following activities occurred: A medication chart was given to
patients that included anti-platelet medication name, dosage, indication, and frequency. The
teach-back method was employed to assess patient understanding and retention. One week postdischarge patients were phoned to confirm discharge medications were filled as well as
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assessment of understanding and timing of anti-platelet medications via the teach-back method.
Patients were reminded of their 30 day clinic appointment and the importance of attending this
visit. Patients were seen at their 30 day standard of care clinic visit to assess adherence at 30
days.
Results and Conclusion: Participation in this project ultimately yielded a significant increase in
anti-platelet medication knowledge from pre-test to post test. Baseline mean pre-test score of
1.30 (SD=.483); participants’ mean score significantly increased to 3.00 (SD=.000). There was
no significant difference between 7 day and 30 day adherence rates and knowledge. Seven day
mean pre-test score of 2.90 (.316) and mean post test score of 3.00 (SD=.000). 100% of study
subjects were taking anti-platelet medications at 7 days and 90% of subjects were taking
medications at 30 days. One study subject was seen in the emergency room within 30 days of
index procedure with reports of shortness of breath and angina. A full cardiac workup concluded
that the stent was patent and anti-platelet medication was changed. It was thought by the
overseeing cardiology service that this subject was a poor responder to current therapy. It is
unknown if this subject was adherent at 30 days because she did not attend the 30 day clinic
visit.
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Background
Definition
Medication adherence has been defined as the active, voluntary, and collaborative
involvement of the patient in a mutually acceptable course of behavior to produce a therapeutic
result (Ho, Bryson, & Rumsfeld, 2009).
Associated Costs
Medication adherence continues to be a growing concern to healthcare providers and
other stakeholders because the relationship between compliance and adverse outcomes has been
linked to higher costs of care. The total cost estimates as a result of medication non-adherence
range from $100 billion to $300 billion annually (Bosworth et al., 2011). The American College
of Preventative Medicine (2011) estimates that non-adherence costs average $2,000 per patient
in physician visits annually. More than forty percent of nursing home admissions are a direct
result of non-adherence and this rate is expected to rise as the number of chronic diseases
increase (Lau & Nau, 2009). It is estimated that for every dollar spent on adhering to a
prescribed medication, medical costs would be reduced by $9.08 (Bosworth et al., 2011).
Morbidity and Mortality
Approximately 125,000 deaths per year in the United States are due to medication noncompliance, and between 33% and 69% of medication related admissions in the United States
are to due to poor adherence (Bosworth et al., 2011). While medications are effective in
combating disease, their full benefits are not often realized because approximately 20%-50% of
patients do not take their medications as prescribed (Brown & Bussell, 2011). Patients who filled
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none of their discharge medications within 120 days after an acute myocardial infarction (AMI)
had an 80% increase in chance of death; those who filled some of their medications had a 44%
increase in chance of death (Jackevicius, Li, & Tu, 2008). Non-adherence can be attributed to
30%-50% of treatment failures and non-adherence leads to worsen outcomes such as increased,
preventable hospitalization rates, and increased healthcare costs (Sokol, McGuigan, Verbrugge,
& Epstein, 2005).
Guidelines
Currently, measurement of patient adherence to medication regimes and the incorporation
of interventions to improve adherence are rarely used in clinical practice. Medication adherence
has been termed the “next frontier in quality improvement” and is an important clinical issue that
needs addressed (Ho, Bryson, & Rumsfeld, 2009). Given the magnitude and importance of poor
medication compliance and programs to aid in this, the World Health Organization has
developed evidence-based guidelines for clinicians, health care managers, and policymakers to
assist in strategies to improve medication compliance (Osterberg & Blaschke, 2005).
Medications are imperative in treatment and disease prevention. It has been reported that
medication use in the United States has risen from approximately 4 drugs prescribed per person
from 1995 to 1996 to 5.2 drugs from 2001 to 2002 (Tarn et al., 2006). Medication non-adherence
may occur at various levels in the patient’s decision-making process. It may occur at the start of
therapy if a patient receives the initial prescription and fails to fill it, or it may occur after
initiation of therapy and the patient fails to comply with instructions or fails to refill the
prescription (Jackevicius, Li, & Tu, 2008). The misuse of medications can result in disease
progression, drug overdose, hospitalizations, and increased healthcare costs. Reasons for overall
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medication non-adherence are reflected in barriers to medication adherence, condition related
factors, socio-economic factors, and communication (Wroth & Pathman, 2006). With the number
of medication use on the rise, it is critical that patients are instructed on the proper use of
prescribed medication regimens. Haskard & DiMattreoo (2009) attribute communication
between healthcare providers and patients regarding medication regimes as significant in
predicting adherence among patients. Adherence requires the patient to believe there is a benefit
to the medication prescribed and agree with the instructions on how to take it. This can be
particularly challenging in the cardiovascular population due to the fact that patients may not see
immediate symptom improvement.
Teach-Back Method
With the increase in the incidence of chronic disease, patient self-management has
become increasingly important. For patients to effectively manage their health conditions they
must effectively understand their disease process, rationales for treatments, medication regimes,
and associated side effects. Jack et al. (2009) found that patients’ understanding of medication at
hospital discharge was approximately 15%, and of those 15%, they were unaware that a new
medication had been prescribed. Additionally, only half reported sufficient understanding of
specific information related to medications, including dosage, dosage schedule, and purpose.
Assessing patients comprehension and recall ability helps predict their adherence to
medical management. For effective teaching and assessment of patient comprehension and
recall, a patient-centered approached must be utilized. The teach-back method confirms patient
understanding and can assist in closing the communication gap between the clinician and patient
while enhancing patient knowledge (Ping, 2012).
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Description of the Practice Inquiry Project
This practice inquiry project implemented an evidenced based, nurse-driven,
multidisciplinary medication discharge process in AMI patients discharged on anti-platelet
medications post percutaneous coronary intervention at a 433 bed community care hospital
located in Central Kentucky. The project took place on a 35 bed post interventional care unit
(4IC). A Pre/Post- test analysis was used at 3 time points to determine the educational impact on
patient knowledge and adherence to prescribed anti-platelet medication.
Goals and Objectives
The objectives of this project were to: (i) assess current barriers and determining factors
associated with medication adherence and how this coincides with health outcomes, (ii) assess
whether medication adherence and hospital re-admission rates were improved with a
comprehensive medication discharge educational plan.
Methods
Approval Process
Following project proposal development and committee approval, clearance was
obtained from the Research Oversight Office at Kentucky One Health. An expedited proposal
was approved by the University of Kentucky Institutional Review Board (IRB). The Chief
Nursing Officer, physicians, advanced practice providers, and the 4IC nursing manger and unit
staff were informed of the project via email and in person communication. Approval was
obtained from the manager of the Post Interventional Care Unit Manager.
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Study Setting:
The project took place on a 35 bed post interventional care unit (4IC) located in a
433 bed community care hospital in Central Kentucky. The hospital is accredited by The Joint
Commission for Accreditation of Hospitals. The hospital is also a designated Society of
Cardiovascular Chest Pain center.
Study Population
The target population for this study was English speaking cardiology patients who
underwent percutaneous coronary intervention and were discharged on anti-platelet therapy.
Eligibility in this study required access to either a land line or cell phone. A total of 12 subjects
were approached for a total of 10 participants.
Procedures
A formal in-service was held with the unit staff and manager providing them with the
details of the project and how this would complement their current practices. Enrolled patients
were identified by screening the daily cath lab schedule. Eligible patients were approached for
consent into this study, and after informed consent, seen prior to hospital discharge. No standard
practices was interrupted by this project; medication reconciliation and all discharge procedures
conducted by the discharge nurse took place, including assessment of financial barriers
associated with medications. As part of this project, a medication chart was given to patients that
included anti-platelet medication name, dosage, indication, and frequency (Appendix A). The
teach-back method was employed by the study PI to assess patient understanding and retention.
One week post-discharge patients were phoned by the study PI to confirm discharge medications
were filled as well as assessment of understanding and timing of anti-platelet medications.
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Patient understanding was confirmed via the teach-back method (Appendix B). Additionally,
patients were reminded of their 30 day clinic appointment and the importance of attending this
visit. Lastly, patients were seen at their 30 day standard of care clinic visit. At this visit
medication adherence was assessed as well as any hospital re-admissions since their index
procedure.
Data Analysis:
Data analysis was performed using SPSS® version 23.0 (SPSS Inc., Chicago, IL). Pre
and post tests were scored and statistically analyzed to assess mean scores prior to, and following
educational intervention. Data were analyzed using descriptive statistics. Paired T-tests were
conducted to compare the differences in mean scores. This study considered values of p < 0.0001
significant for the analysis.
Results
Sample Characteristics
A total of 12 subjects were approached who met the inclusion criteria for the study, and
10 subjects voluntarily participated in the study. Thirty percent of participants were Caucasian
females and 70% were Caucasian males. Mean age was 63.6 years old (SD=10.5). All but 1
study subject completed all required visits for a completion rate of 90%. Reason provided by the
2 subjects who declined participation was access to a reliable phone and time commitment
requirement.
Study Results
Participation in this project ultimately yielded a significant increase in anti-platelet
medication knowledge from pre-test to post test. Baseline mean pre-test score of 1.30 (SD=.483);
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participants’ mean score significantly increased to 3.00 (SD=.000). There was no significant
difference between 7 day and 30 day adherence rates and knowledge. Seven day mean pre-test
score of 2.90 (.316) and mean post test score of 3.00 (SD=.000) (Figure 1). One hundred percent
of study subjects were taking anti-platelet medications at 7 days and 90% of subjects were taking
medications at 30 days.
One study subject was seen in the emergency room within 30 days of index procedure
with complaints of shortness of breath and angina. A full cardiac workup concluded that the stent
was patent and anti-platelet medication was changed. It was thought by the overseeing
cardiology service that this subject was a poor responder to current therapy. It is unknown if this
subject was adherent at 30 days because she did not attend the 30 day clinic visit.
Discussion
Guidelines from the American College of Cardiology, American College of Preventive
Medicine, and the World Health Organization recommend clinicians implement strategies to
improve medication adherence. Physicians and Advanced Practice Providers play an integral role
in this process. Numerous studies have demonstrated a correlation between provider trust and
adherence. A meta-analysis performed by Haskard and DiMatteo (2009) on provider
communication and patient adherence found there was a 19% higher risk of non-adherence
among patients whose provider communicates poorly compared to those providers who
communicate well. Statically, the odds of patient adherence are 2.26 times higher if the provider
communicates well. This translates into more than 183 million avoidable medical visits when
strong provider/patient communication is present (Haskard and DiMatteo, 2009). Time has also
been identified as a barrier in provider/patient communication. Studies have shown that some
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patients are interrupted by their provider after an average of 22 seconds. It has also been
demonstrated that when patients are allowed to speak freely, the average patient would speak
initially for less than 2 minutes (McDonald, Gary, & Haynes, 2009). By opening the lines of
communication this will allow for the acceptance of new medication, adherence to medication
regimes, which will ultimately lead to improvement in health outcomes (American College of
Preventative Medicine, 2011).
Follow-up appointments after hospitalizations may also be a predictor of medication
adherence. A study that included 20,976 patients looked at the effect of follow-up appointments
in patients who were post AMI. Researchers found that at three months post AMI, one in three
patients were no longer adherent to medications, including anti-platelet medications. It was also
indentified that patients who had their first follow-up appointment within 4-6 weeks post
discharge had significantly better adherence rates at both 90 days and one year compared with
those who followed-up later or did not follow-up at all (Faridi et al., 2016).
Brown and Bussell (2011) assert that while the provider has an integral role in this
process, the patient must take an active role as well. It has been reported that a typical patient
recalls as little as 50% of what is discussed at a medical encounter. Effective patient education
must be multi-factorial, individualized, and delivered in a variety of ways outside the four walls
of a hospital (Brown & Bussell, 2011). A key component of an adherence improving plan must
be education. The more empowered the patient feels, the more likely they are to be motivated to
manage their disease and adhere to treatment guidelines. Additional measures to ensure
adherence is to actively involve the patient whenever possible in treatment decisions. By actively
involving patients and offering choices, this will encourage active participation in their

10

healthcare and hopefully facilitate adherence to medication regimes (Garner, 2010).
Using the teach-back approach is another method of confirming understanding and
actively engaging the patient. During the teach-back process, the patient makes the transition
from having their disease managed by the provider to managing it themselves. When teach-back
is used, providers reinforce what the patient already knows and teach them what they do not. By
repeating this process as part of the interactive communication loop, this increases patients’ selfcare capacity abilities (Maniaci, Heckman & Dawson, 2008).
This practice inquiry project was designed to improve knowledge surrounding antiplatelet medication in the post AMI/PCI patient population. The results showed a statistically
significant difference in patient knowledge and understanding from baseline pre/post test
evaluation and continued retention through 30 days. Additionally, pre test data revealed that post
AMI/PCI patients are not adequately being educated on anti-platelet medication use prior to
hospital discharge.
Implications for Practice
Medication adherence has a tremendous impact on the healthcare system due to increased
risks of mortality and hospital readmissions; it is not solely a patient problem. The results of this
practice inquiry project suggest that improving patient knowledge surrounding medication
regimes and encouraging self-management techniques could influence the patient’s decision
making process, and with further research, implement evidenced based strategies targeted at
adherence interventions. This is supported by recommendations from the American College of
Cardiology, American College of Preventive Medicine, and the World Health Organization.
Moreover, further research is needed to explore the impact of the discharge nurse in developing a
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standardized discharge process and the role this plays in medication adherence. By implementing
these types of practices throughout an institution, we can ensure that patients are equipment with
the necessary tools to be an active participant in their healthcare.
Implications for Future Inquiry
Future studies need to include a larger sample size and a more diverse patient population.
Additional considerations may include a different study design or the addition of a control group
to validate the hypothesis and a follow-up period of 1 year. The teach-back method has been
demonstrated as an effective approach in increasing adherence, but there is little research with
using this method in the AMI/PCI patient population. This small study utilized this method and
was found to be successful in the 10 patients enrolled, but a larger sample is needed to validate
this. Research has demonstrated that patients who had their first follow-up appointment within 46 weeks following discharge have significantly better adherence rates at 90 days and one year
compared with those who were lost to follow-up. Measures to ensure follow-up appointments are
made prior to discharge and then reminders sent to patients prior to scheduled appointments
should be standard practice. Lastly, findings should be published in medical journals to help
guide future practice and research.
Limitations
Due to a small study sample (n=10), a larger study sample is needed to adequately
demonstrate effectiveness and advocate the need for practice change. The sample is also
comprised of all Caucasians, so this may not be a true representation of the population as a
whole, nor generalizable to a diverse set of patients. Follow-up beyond 30 days was not feasible
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in this study due to time constraints; however future research should be targeted to include a
larger sample size and follow-up through 1 year to gain a better understanding of contributing
factors associated with medication adherence in the AMI/PCI patient population.
Conclusion
With the rising incidence of chronic disease, patient self-management is becoming
increasingly important. An easy and cost effective way to assist with this is incorporating the
teach-back method into practice. Using this technique can improve patient knowledge, outcomes,
and self-management skills. Based on the findings from this study, evidence-based education in
the form of the teach-back method was successful in improving medication adherence rates in
the AMI/PCI patient population 30 days post index procedure. Due to limitations in this study,
researchers were unable to demonstrate long-term effects of teach- back method in regards to
medication adherence. However, a significant increase in baseline knowledge of medications
made the patients feel as if they were taking an active part in their healthcare management,
therefore, equipped with the necessary knowledge to make informed decisions. This is promising
and warrants further investigation. Given the lack of research on this subject in the AMI/PCI
patient population, further research is recommended to expand on this educational intervention in
order to design, implement and evaluate programs that are effective and sustainable over time.
As stated by Benjamin Franklin, “Tell me and I forget. Teach me and I remember. Involve me
and I learn.”
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Table 1: Strategies and No-Cost Resources
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Figure 1: Difference in mean knowledge scores (N=10)
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Appendix A: IRB Approval Letter
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Appendix B: Medication Chart

Medication Chart for XXXXXXXX

Name of
Medication

Dosage

Frequency
(how often)
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Indication

Appendix C: Phone Script
One Week Phone Call Script and Data Collection Sheet

Hello, may I speak with Ms./Mr. X,

My name is Rebecca Thomas and I am a graduate student at the University of Kentucky. We met during
your recent hospitalization at Saint Joseph Hospital. To refresh your memory, prior to discharge from
the hospital we discussed your medications and you gave me permission to phone you, do you
remember that? If so, do you still agree to be a part of this program?
If patient agrees proceed with the following.
I was wondering if you have a few minutes for me to go over your medications using the list we
reviewed while you were in the hospital, do you have that? Also, can you bring all your medications to
the phone, please? We will review them during this call. I will hold while you collect all of your
medications, there is no need to hurry.
Caller (PI): Do you have all of your medications and the list in front of you now?
Caller (PI): I’m going to ask you a few questions about each one of your medications to see if there is
anything I can help you with. We will go through your medications one by one.
First of all, I want to make sure you were able to obtain all of the medications you were discharged
home with, did you do this? If not, why?
Next we will discuss how often you take each medication, any problems you have had and any questions
you might have about them.
Let’s start with the first medication on the list.
-

What is the name of the medication? If the patient is using a generic, make sure they understand
that the brand and generic names are two names for the same medication.
What is the dosage of this medication?
How much do you take each time?
What do you take this medicine for?
Do you have any problems or concerns with this medicine?
Do you think you are experiencing any side effects with this medication?
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If the patient has been prescribed any medication that the patient hasn’t mentioned, ask whether or
not they are taking that medication.
18
If the patient is not taking the medication, ask why not.
Caller (PI): Have you been using the medication chart that was provided to you prior to discharge?
If yes, provide positive reinforcement of this tool.
If no, suggest using this tool to help remember to take medicines as directed.
Caller (PI): What questions do you have today regarding your medicines and/or medication chart?
Appointment Reminder
Caller (PI): I want to make sure you remember to come to your appointment with Dr. X on X. You were
given an appointment with your doctor when you left the hospital. Can you please tell me:
-

When is your appointment?
Where is your appointment?
Are you able to make this appointment? If the patient can’t make the appointment, instruct to
reschedule as close to the date of the originally scheduled appointment and stress the
importance of attending this visit. Make sure the patient has the clinic phone number on hand.

Caller (PI): Please remember to bring your medication chart to your scheduled appointment on XX.
Caller (PI): In addition to this call you will also receive a call from Dr. X’s clinic two days prior to your
appointment to remind you of the date. At that time if you are unable to attend that appointment
please make sure you reschedule this visit.
Caller (PI): Do you have any questions at this time?
Caller (PI): Thank you for your time, good bye. I look forward to seeing you on xxxxx.
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